Abstract
The serine-threonine kinase CK2 exhibits genomic alterations and aberrant overexpression in human head and neck squamous cell carcinomas (HNSCC). Here, we investigated the effects of CK2 inhibitor CX-4945 in human HNSCC cell lines and xenograft models. The IC50's of CX-4945 for 9 UM-SCC cell lines measured by MTT assay ranged from 3.4-11.9 μM. CX-4945 induced cell cycle arrest and cell death measured by DNA flow cytometry, and inhibited prosurvival mediators phospho-AKT and p-S6 in UM-SCC1 and UM-SCC46 cells. CX-4945 decreased NF-κB and Bcl-XL reporter gene activities in both cell lines, but upregulated proapoptotic TP53 and p21 reporter activities, and induced phospho-ERK, AP-1, and IL-8 activity in UM-SCC1 cells. CX-4945 exhibited modest anti-tumor activity in UM-SCC1 xenografts. Tumor immunostaining revealed significant inhibition of PI3K-Akt-mTOR pathway and increased apoptosis marker TUNEL, but also induced p-ERK, c-JUN, JUNB, FOSL1 and proliferation (Ki67) markers, as a possible resistance mechanism. To overcome the drug resistance, we tested MEK inhibitor PD-0325901 (PD-901), which inhibited ERK-AP-1 activation alone and in combination with CX-4945. PD-901 alone displayed significant anti-tumor effects in vivo, and the c...Continue Reading
Citations
Nov 14, 2015·Expert Opinion on Therapeutic Targets·Giorgio Cozza, Lorenzo A Pinna
Nov 8, 2015·Advanced Drug Delivery Reviews·Jessica A KempYoung Jik Kwon
Apr 8, 2016·Expert Opinion on Investigational Drugs·Paolo Bossi, Salvatore Alfieri
Nov 9, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Szu-Ting ChouJulia Y Ljubimova
Jan 31, 2017·Pharmaceuticals·Melissa M J ChuaIsabel Dominguez
Feb 18, 2017·Pharmaceuticals·Laura Ferrer-FontAna Paula Candiota
Feb 15, 2017·Pancreas·Dae Wook HwangJae Cheol Lee
Dec 6, 2017·PloS One·Melissa M J ChuaIsabel Dominguez
Sep 28, 2018·PLoS Biology·Min PanOlivier Gires
Sep 6, 2017·PloS One·Anna Maria LustriDomenico Alvaro
Jul 7, 2019·Journal of Experimental & Clinical Cancer Research : CR·Christian Borgo, Maria Ruzzene
Nov 9, 2017·Oncotarget·Mary GlorieuxSandra Nuyts
Jul 28, 2016·Oncotarget·Jed J KendallNancy Ratner
Aug 10, 2017·Scientific Reports·Hao XuQian-Ming Chen
Aug 28, 2020·Cancer Management and Research·Xinghai WuYun Bai
Aug 26, 2018·Cancers·Jomnarong LertsuwanJutamaad Satayavivad
Dec 14, 2016·Oncology Reports·Kengo TakahashiSetsuro Komiya
Sep 13, 2018·Science Signaling·Teresa PurznerMatthew P Scott
Feb 6, 2021·Cancers·Sofia GiacosaOdile Filhol
Feb 15, 2021·Experimental Cell Research·Hu ZhouXiang Zhu
Jun 3, 2021·Journal of Clinical Medicine·Panagiotis GarantziotisEleni Frangou
Oct 15, 2020·Cellular Oncology (Dordrecht)·Claudio D'AmoreMauro Salvi